Royalty Pharma plc Files Q1 2025 10-Q
Ticker: RPRX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1802768
| Field | Detail |
|---|---|
| Company | Royalty Pharma PLC (RPRX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Royalty Pharma Q1 2025 10-Q is in. Financials look steady.
AI Summary
Royalty Pharma plc filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and segment information are presented, reflecting the company's ongoing business activities in the pharmaceutical royalty sector.
Why It Matters
This filing provides investors with the latest financial snapshot of Royalty Pharma plc, crucial for understanding its performance and making informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-05-08 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Royalty Pharma plc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- 110 EAST 59TH STREET (location) — Company's business and mailing address
- NEW YORK (location) — Company's business and mailing city
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is the company's primary industry classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
What is the fiscal year end for Royalty Pharma plc?
The fiscal year end for Royalty Pharma plc is December 31.
What is the company's business address?
The company's business address is 110 East 59th Street, New York, NY 10022.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Royalty Pharma plc (RPRX).